|
|
||||||||
1 From the Departments of Ophthalmology and 2 Clinical Chemistry, University of Lund, Sweden.
| Abstract |
|---|
|
|
|---|
METHODS. Enzyme-linked immunosorbent assay (ELISA), reverse transcriptionpolymerase chain reaction (RT-PCR), DNA sequencing, Western blot analysis, and immunohistochemistry have been used on mouse, rat, and human retinas (pigment epithelium included).
RESULTS. Cystatin C is present in high concentrations in the normal adult rat retina, as it is throughout its postnatal development. Its concentration increases to a peak at the time when rat pups open their eyes and then remains at a high level. It is mainly localized to the pigment epithelium, but also to some few neurons of varying types in the inner retina. Cystatin C is similarly expressed in normal mouse and human retinas.
CONCLUSIONS. Cystatin C was identified and the localization described in the retinas of rat, mouse, and human using several techniques. Cystatin C is known to efficiently inactivate certain cysteine proteases. One of them, cathepsin S, is present in the retinal pigment epithelium and affects the proteolytic processing by cathepsin D of diurnally shed photoreceptor outer segments. Hypothetically, it appears possible that retinal cystatin C, given its localization to the pigment epithelium and its ability to inhibit cathepsin S, could be involved in the regulation of photoreceptor degradation.
| Introduction |
|---|
|
|
|---|
Cystatins regulate the activity of family C1 cysteine proteases by reversible binding to their active-site clefts in competition with enzyme substrate. Known mammalian cystatins are all composed of at least one 100- to 120-amino-acid-residue domain with conserved sequence motifs.4 Of the 11 human cystatins known, cystatin C is the most extensively studied, showing a wide-spectrum inhibition profile and high-affinity binding to virtually all family C1 cysteine proteases.1 It is the dominating inhibitor in most body fluids, present in amounts allowing it to control the extracellular activities of cathepsin B and other family C1 cysteine proteases.5
The concentration of human cystatin C is markedly higher in cerebrospinal fluid than in blood.5 The highest amounts of cystatin C in tissue homogenates from human, mouse, and rat are found in brain samples, at levels of 30 to 300 ng/mg protein.6 It has been shown that cystatin C is expressed in rat, monkey, and human cerebral neurons.7 8 9
The retina is ontogenetically a part of the central nervous system (CNS) and cystatin C might therefore be expected in retinal neurons as well. It has been shown by in situ hybridization that cystatin C mRNA is present in the rat retina,10 but the precise retinal distribution of the protein, to our knowledge, has not been studied so far. Further, it has been shown that the production of cystatin C is upregulated in the CNS after ischemia or axotomy,11 12 suggesting that it may play a role in neurodegeneration, neuroprotection, or repair. When it was further shown that the retinal pigment epithelium produces factor(s) with cysteine protease inhibitory characteristics, which may be of importance in retinal development or normal maintenance,13 we decided to analyze the content and distribution of cystatin C in the retina.
| Materials and Methods |
|---|
|
|
|---|
All dissection work was performed in freshly prepared Ames medium (Sigma-Aldrich Chemie, GmbH, Steinheim, Germany)14 that had been bubbled with a mixture of 95% oxygen and 5% carbon dioxide. The rats were killed by carbon dioxide asphyxiation and the mice by decapitation. Tissues were fixed at 4°C for 4 hours in 4% formaldehyde in 0.1 M phosphate buffer at pH 7.4 and processed for immunohistochemistry. Developing rat eyes were obtained at embryonic day 15 and 18 (E15 and E18), day of birth (PN0) and postnatal day (PN)7, 14, 21, 28, and 35 and prepared for immunohistochemistry in the same way as for adult tissue. The age of the embryos were determined by measuring their crownrump lengths. For protein and RNA analyses, the retinas (pigment epithelium included) were dissected and instantly frozen on dry ice and stored at -80°C awaiting further preparation.
Nucleotide-Based Analyses
Total RNA was prepared from tissue samples as
described.15
RT-PCR was performed using commercial
reagents (PE Applied Biosystems, Foster City, CA). For rat cystatin C,
the primer pair used had the sequences 5'-AGG AGA AGA GAA CCA GGG GAC
AGC3-' (KH727) and 5'-AGT ACA ACA AGG GCA GCA ACG ATG-3' (KH728). For
amplification of a mouse cystatin C cDNA segment, the primers KH723,
5'-CCA TGA CCA GCC CCA TCT GAT-3', and KH724, 5'-CAC AAG TAA GGA ACA
GTC TGC-3', were used. PCR was accomplished using 0.4 µM primers and
Taq polymerase (AmpliTaq Gold; PE Applied
Biosystems) in a thermocycler (2400; PE Applied Biosystems), with 35
cycles of denaturation at 94°C, 30 seconds; annealing at 58°C, 30
seconds; and extension at 72°C, 30 seconds, with a 5-minute
preincubation time at 94°C before the temperature cycling. PCR
products were analyzed by electrophoresis in 2% agarose gels. The DNA
sequences of PCR products were determined on both strands by dye
dideoxy sequencing, using reagents in the sequencing kit (BigDye
Terminator Cycle Sequencing; PE Applied Biosystems); oligonucleotides
KH723, 724, 727, or 728 as primers; and a sequencer (310; PE Applied
Biosystems). The sequences were evaluated by computer (Sequencher; Gene
Codes Corp., Ann Arbor, MI).
Antibodies
The monospecific polyclonal rabbit antisera used for ELISA,
immunoblot analysis, and immunohistochemistry were raised against
cystatin C isolated from human urine,5
recombinant mouse,
and rat cystatin C.6
The antibodies against human cystatin
C cross-react with mouse and rat cystatin C.6
Of the three
cystatin C antisera, the one raised against human cystatin C elicited
the best immunohistochemical labeling and was therefore predominantly
used. The two others did not result in any deviating observations.
Secondary antibodies conjugated to FITC or Texas red and raised against rabbit IgG were obtained from Southern Biotechnology Associates, Inc. (Birmingham, AL), and Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA), respectively.
Cystatin C ELISA
Cystatin C was assayed as previously described.6
Recombinant mouse or rat cystatin C were used for appropriate
calibration curves. The cystatin C concentration was related to total
protein concentration in the homogenates, the latter measured by a
dye-binding assay.16
Western Blot Analysis
Immunoblot analysis to detect cystatin C after electrophoretic
separation of proteins in tissue homogenates was performed as
described,17
using 16.5% SDS-polyacrylamide gels.
Reference samples included recombinant human, mouse and rat cystatin
C.6
18
Immunohistochemistry
Cryostat sectioning (12 µm) and immunolabeling were performed
with standard procedures. Labeling control experiments included using
different secondary antibodies, omitting the primary antibodies, and
preabsorbing the primary antibodies with excess recombinant human
cystatin C.
Microscopy and Image Analysis
The specimens were examined using a epifluorescence microscope
(Eclipse E800; Nikon) equipped with a digital acquisition system
(DEI-750; Optronics Engineering, Goletta, GA) and with a confocal laser
scanning microscope (MRC1024UV; Bio-Rad, Richmond, CA). Images were
viewed and processed using image analysis software (Confocal Assistant;
free software, copyright Todd Clark Brelje, University of Minnesota,
Minneapolis; and Photoshop; Adobe Systems, Mountain View, CA).
Autofluorescence can be disturbing in the human pigment epithelium. Confocal scanning images were therefore obtained in selected regions with low lipofuscin autofluorescence and at two different wavelengths, one at 488/529 nm and one at 568/598 nm (excitation/emission wavelengths). The FITC-labeled antibody is known to elicit only weak signal in the 568/598-nm channel, which was also checked in independent model preparations. Care was taken to keep all image information well within the dynamic range of the confocal microscope, allowing subtraction images to be made without aberration caused by out-of-range fluorescence intensities. Fluorescence in the 488/529-nm channel that did not appear in the 568/598-nm channel was taken to be specific FITC fluorescence. For control purposes, the autofluorescence was studied in nonlabeled specimens, and subtracted images were made from such images, to affirm that the autofluorescence was similar in both channels, allowing such subtraction images to be made on the labeled sections.
| Results |
|---|
|
|
|---|
|
|
|
At times, and again with variations between different animals, a small number of neurons with the localization and morphology of amacrine cells, bipolar cells, horizontal cells, and cone photoreceptor cells were labeled by the cystatin C antibody. Typically, these cells were few and scattered (Fig. 3D) . Horizontal cells were more common than bipolar and amacrine cells, and only occasional cone cells could be found. The cells appeared to be labeled in their entirety, which allowed us to identify them as belonging to the different cell classes.
Control experiments using different secondary antibodies resulted in consistent staining. In experiments in which the primary antibody had been omitted or preabsorbed by using recombinantly produced antigen, there was no immunoreactivity in the retina (Fig. 3E) .
In mouse (Fig. 3F) and human retinas, the staining was similar to that in the rat retina. The subcellular localizaton of the human cystatin C was examined in composite greenred (Fig. 4A) pictures and in images in which the autofluorescence recorded in the 568/598-nm channel had been subtracted (Fig. 4B) . It was different in many places from that of the autofluorescent lipofuscin granules. The autofluorescence in nonlabeled specimens was very close to identical in the 488/529- and 568/598-nm channels (Figs. 4C 4D) . In composite greenred pictures from nonlabeled sections, such channel subtraction completely eliminated the staining in the RPE (not illustrated).
|
The distribution of the immunoreactivity was similar at all stages to the pattern observed in adult animals. Thus, primarily the pigment epithelial cells were labeled, but also a small number of other retinal neurons of different classes.
Analysis of tissue homogenates showed a gradual increase in retinal cystatin C content throughout development, reaching a peak at approximately day 14, after which a slight decline may have occurred (Fig. 5) .
|
| Discussion |
|---|
|
|
|---|
The detection at the protein level of cystatin C in homogenates of adult rat and mouse retinas (with the pigment epithelium included), using these antibodies, is corroborated by the identification of cystatin C mRNA in such homogenates. According to our immunoassays, the inhibitor concentrations were, in the two species, more than 90 and more than 20 ng/mg protein, which is significantly higher than in homogenates from most tissues (liver, kidney, spleen, and muscle) of both animals, and of the same order as in homogenates of whole rat or mouse brain.6 We therefore conclude that relatively high amounts of cystatin C are synthesized in the retina and retinal pigment epithelium.
At the cellular level, cystatin C was seen in all cells of the retinal pigment epithelium. Certain ganglion, amacrine, bipolar, and horizontal cells and cones occasionally also showed cystatin C immunoreactivity. The distribution of cystatin C immunoreactivity was consistent and comparable in retinas of rats, mice, and humans. Based on the results presented here, we propose that cystatin C is localized to the retinal pigment epithelium as well as to some few neurons of different types in the inner retina. To our knowledge, this is the first direct examination of the distribution of a cysteine protease inhibitor in the retina.
The presence of retinal cystatin C was previously investigated with an indirect method assaying cystatin C mRNA by in situ hybridization,10 thus showing putative production sites. Our immunolocalization of the actual protein confirms the presence of cystatin C in the retina, but it appeared in structures other than the ones noted with in situ hybridization. However, expressed-sequence tag (EST) analyses of mRNA from cultured human retinal epithelial cells show the presence of cystatin C transcripts in these cells,21 22 indicating that the protein we detect at least partially is located at its site of synthesis. Furthermore, in this study, specific ELISA showed that in the rat retina, cystatin C was present in fetal tissue from stage E18 and was expressed throughout the development of the retina, as well as in the adult retina, reaching a maximum at approximately PN14. Immunohistochemistry has shown that the distribution of cystatin C remains essentially the same throughout development and that the pattern is the same as that in the adult retina.
The increase in retinal cystatin C content during the early development of the retina suggests that it may have a specific function controlling the development of the tissue. Because there was no addition of new cystatin C immunoreactive cell types during development, it appears likely that the increase reflects an increased production of cystatin C in predominantly the pigment epithelial cells.
Cystatin C is expressed by neurons and glial cells in the rat CNS.7 In the brain, the expression of cystatin C is upregulated after ischemia11 or facial nerve axotomy.12 Considering the similarities between the brain and the retina, cystatin C may have similar protective or regulatory functions in the event of pathologic or traumatic lesions affecting the retina.
Based on the results presented herein, we propose that cystatin C is continuously present at a fairly high level in the retinal pigment epithelium as well as occasionally in retinal neurons of most classes. The increase in the amount of cystatin C present in the retina coinciding with the time when the photoreceptor cells mature at approximately PN14 raises the hypothesis that it may participate in regulating the degradation of photoreceptor outer segment proteins, potentially by affecting the activity of cathepsin S. This hypothesis is based on the fact that cathepsin S is present in the retinal pigment epithelium,23 where it can regulate the activity of cathepsin D,24 which is the predominant protease involved in photoreceptor outer segment degradation.25 26 27 Further, cystatin C is a strikingly good cathepsin S inhibitor in vitro1 and is a likely physiological regulator of cathepsin S activity. For example, the cystatin Ccathepsin S balance appears to control antigen presentation by dendritic cells,28 and it is important for the maintenance of normal vessel walls.29 The cystatin C we have demonstrated in the retinal pigment epithelium may influence the (cathepsin Scathepsin D) system.
| Footnotes |
|---|
Submitted for publication July 24, 2000; revised October 30 and December 15, 2000, and February 5, 2001; accepted February 16, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Johan Wassélius, Department of Ophthalmology, WRC, BMC, B13, Lund University Hospital, S-221 84 Lund, Sweden. johan.wasselius{at}oft.lu.se
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Ahuja, P. Ahuja-Jensen, L. E. Johnson, A. R. Caffe, M. Abrahamson, P. A. R. Ekstrom, and T. van Veen rd1 Mouse Retina Shows an Imbalance in the Activity of Cysteine Protease Cathepsins and Their Endogenous Inhibitor Cystatin C Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1089 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gamm, J. N. Melvan, R. L. Shearer, I. Pinilla, G. Sabat, C. N. Svendsen, and L. S. Wright A Novel Serum-Free Method for Culturing Human Prenatal Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 788 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rohrer, F. R. Pinto, K. E. Hulse, H. R. Lohr, L. Zhang, and J. S. Almeida Multidestructive Pathways Triggered in Photoreceptor Cell Death of the RD Mouse as Determined through Gene Expression Profiling J. Biol. Chem., October 1, 2004; 279(40): 41903 - 41910. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Van Den Berghe, K. Sainton, K. Gogat, D. Marchant, E. Dufour, S. Bonnel, S. Gadin, M. Menasche, and M. Abitbol Prosaposin Gene Expression in Normal and Dystrophic RCS Rat Retina Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1297 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zurdel, U. Finckh, G. Menzer, R. M Nitsch, and G. Richard CST3 genotype associated with exudative age related macular degeneration Br. J. Ophthalmol., February 1, 2002; 86(2): 214 - 219. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |